Spectrum of opportunistic infections in relation to CD4 count in HIV-2 patients

 

 

REFERENCES

1. Haynes BF, Pantaleo G, Fauci AS. Towards an understanding of the correlates of protective immunity to HIV infection. Science 1996; 271:324-8.
2. Pantaleo G, Fauci AS. Immunopathogenesis of HIV infection. Annu Rev Microbiol 1996; 50: 825-54.
3. Centers for Disease Control (CDC). Update on acquired immune deficiency syndrome (AIDS) — United States. Morb Mortal Wkly Rep 1982; 31:507-8, 513-4.
4. Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM. Preventing opportunistic infections in human immunodeficiency virus-infected persons: Implications for the developing world. Am J Trop Med Hyg 1996; 55:1-11.
5. Selik RM, Haverkos HW, Curran JW. Acquired immune deficiency syndrome (AIDS) trends in the United States, 1978-1982. Am J Med 1984; 76: 493-500.
6. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996; 124: 633-42.
7. Finkelstein DM, Williams PL, Molenberghs G, Feinberg J, Powderly WG, Kahn J, et al. Patterns of opportunistic infections in patients with HIV infection. J Acquire Immune Defic Syndr Hum Retrovirol 1996; 12: 38-45.
8. Banerjee U, Dutta K, Majumdar T, Gupta K. Cryptococcosis in India: Awakening of a giant? Med Mycol 2001; 39: 51-67.
9. World Health Organization. Guidelines on Standard Operating Procedure for Laboratory Diagnosis of HIV- Opportunistic Infections. New Delhi. Ed Kumari S. 2001.
10. Marques SA, Robles AM, Tortorano AM, Tuculet MA, Negroni R, Mendes RP. Mycoses associated with AIDS in the third world. Med Mycol 2000; 38: 269-79.
11. Shroff HJ, Dashatwar DR, Deshpande RP, Waigmann HR. AIDS-associated Kaposi’s sarcoma in an Indian female. J Assoc Physicians India. 1993; 41: 241-2.
12. Andersson S, Norrgren H, DaSilva Z, et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: Significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infections. Arch Intern Med 2000; 160: 3286-3293.
13. Marlink R, Kani P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265: 1587-1590.
14.  De Silva TI, Cotten M, Rowland-Jones SL. HIV-2: The forgotten AIDS virus. Trends Microbiol 2008; 16: 588-595.
15. Wortley PM, Chu SY, Diaz T, Ward JW, Doyle B, Davidson 3. AJ, et al. HIV testing patterns: where, why, and when were persons with AIDS tested for HIV? AIDS 1995; 9: 487-92.
16. Kumarasamy N, Solomon S, Chaguturu SK, Cecelia AJ, 4. Vallabhaneni S, Flanigan TP, et al. The changing natural history of HIV disease: Before and after the introduction of generic antiretroviral therapy in Southern India. J Clin Infect Dis 2005; 41: 1525-8.
17. Arminio Monfote A, Vago L, Lazarin A, Boldorini R, Bini T, Guzzetti S, et al. AIDS defining illnesses in 250 HIV-infected patients: a comparative study of clinical autopsy diagnosis. AIDS 1992; 6: 467-74.
18. Mohar A, Romo J, Salido F, Jessurun J, Ponce de Leon S, Reyes E, et al. The spectrum of clinical and pathological manifestations of AIDS in consecutive series of autopsied patients in Mexico. AIDS 1992; 6: 467-73.
19. Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Inf Dis 2003; 36: 79-85.
20. Mirdha BR. Mycobacterium avium-intracellulare in stool in HIV-seropositive man. Indian J Gastroenterol 2003; 22: 25.
21. Kumarasamy N, Solomon S, Yesudian P, Sugumar P. First report of Kaposi’s sarcoma in an AIDS patient from Madras, India. Indian J Dermatol 1996; 41: 23-5.
22. Lanjewar DN, Bhosale A, Iyer A. Spectrum of dermatopathologic lesions associated with HIV/AIDS in India. Indian J Pathol Microbiol 2002; 45: 293-8.
23. Shroff HJ, Dashatwar DR, Deshpande RP, Waigmann HR. AIDS-associated Kaposi’s sarcoma in an Indian female. J Assoc Physicians India. 1993; 41: 241-2.
24. van der Loeff MF, Larke N, Kaye S, et al. Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village. Retrovirology 2010; 7: 46.